gadolinium 3,6,10- tri(carboxymethyl)- 3,6,10- triazadodecanedioic acid

Also Known As:

Gd-TTDA

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Prostatic Neoplasms (Prostate Cancer) 02/01/2011 - "Hence, targeting of prostate cancer cells was observed under in vitro and in vivo MR imaging studies using Gd-TTDA-NP-BN contrast agent. "
2.	Neoplasms (Cancer) 02/01/2011 - "We conclude that Gd-TTDA-NP-BN and Gd-TTDA-NP-BN-Cy5.5 can be potentially used as the contrast agents for targeting GRP receptor overexpressing cells and tumors."
3.	Colonic Neoplasms (Colon Cancer) 02/01/2011 - "In addition, an 8-amino acid Bombesin analogue (BN) peptide substrate, which can target prostate, breast, and colon cancer, was synthesized by solid-phase peptide synthesis and subsequently conjugated with [Gd(TTDA-NP)(H(2)O)](2-) to form BN conjugated Gd-TTDA-NP-BN. "